Pharming Group to participate in November investor conferences
November 01 2023 - 3:00AM
Pharming Group to participate in November investor conferences
Leiden, The Netherlands, November 1,
2023: Pharming Group N.V. (“Pharming”) (Euronext
Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management
will participate in the following investor conferences in the month
of November:
- Stifel
2023 Healthcare Conference, New York, November 14-15Anurag
Relan, Chief Medical Officer will participate in a fireside chat,
question and answer session on Tuesday, November 14 at 08:35 am
ET/14:35 CET.
-
Jefferies London Healthcare Conference 2023, London, U.K.,
November 14-16Sijmen de Vries, Chief Executive Officer
will present on Wednesday, November 15 at 08:30 GMT/09:30 CET.
For more information about these conferences, or
to schedule a one-to-one meeting with Pharming’s management team,
please contact Pharming’s Investor Relations team at
investor@pharming.com or your Stifel or Jefferies
representative.
About Pharming Group N.V.
Pharming Group N.V. (Euronext Amsterdam:
PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated
to transforming the lives of patients with rare, debilitating, and
life-threatening diseases. Pharming is commercializing and
developing an innovative portfolio of protein replacement therapies
and precision medicines, including small molecules, biologics, and
gene therapies that are in early to late-stage development.
Pharming is headquartered in Leiden, Netherlands, and has employees
around the globe who serve patients in over 30 markets in North
America, Europe, the Middle East, Africa, and Asia-Pacific.
For more information, visit www.pharming.com and
find us on LinkedIn.
For further public information,
contact:
Pharming Group, Leiden, The
NetherlandsMichael Levitan, VP Investor Relations &
Corporate CommunicationsT: +1 (908) 705 1696
Heather Robertson, Investor Relations &
Corporate Communications ManagerE: investor@pharming.com
FTI Consulting, London, UK
Victoria Foster Mitchell/Alex Shaw/Amy ByrneT:
+44 203 727 1000
LifeSpring Life Sciences Communication,
Amsterdam, The NetherlandsLeon MelensT: +31 6 53 81 64
27E: pharming@lifespring.nl
Pharming Group NV (EU:PHARM)
Historical Stock Chart
From Apr 2024 to May 2024
Pharming Group NV (EU:PHARM)
Historical Stock Chart
From May 2023 to May 2024